Skip to main content

Table 1 Characteristics of patients with psoriasis at baseline

From: Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis

  Overall Isolated HBcAb positive HBcAb/HBsAb positive HCV-Ab positive
N° of patients 224 23 36 15
Age, yrs (mean ± SD) 49 [±13.3] 66 [±10.6] 52 [±12.4] 62 [±11.8]
Gender (M/F) N°% 135/89 [60.2/39.7%] 10/13 [43.4/56.5%] 27/9 [75/25%] 11/4 [73.3/26.6%]
Pso 113 [50.5%] 10 [43.5%] 22 [61.1%] 9 [60%]
PsA 111 [49.5%] 13 [56.5%] 14 [38.9%] 6 [40%]
ALT, U/L (mean ± SD) 23 [±5.3] 27 [±2.3] 24 [±3.2] 25 [±2.1]
HBV-DNA positivity 0/224 0/23 0/36 0/15
HCV-RNA positivity 9/224 0/23 0/36 9/15
HBsAg positivity 0/224 0/23 0/36 0/15